Back to resultsPredictive Values of Serotonergic Alterations for Outcome - 2
Primary Purpose
Cocaine-Related Disorders
Status
Terminated
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Fenfluramine
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring cocaine dependence
Eligibility Criteria
Please contact site for information.
Sites / Locations
- VA Medical Center
Outcomes
Primary Outcome Measures
Side effects
Neuroendocrine changes
Psychological changes
Craving
Secondary Outcome Measures
Full Information
NCT ID
NCT00000313
First Posted
September 20, 1999
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
VA Office of Research and Development
1. Study Identification
Unique Protocol Identification Number
NCT00000313
Brief Title
Predictive Values of Serotonergic Alterations for Outcome - 2
Official Title
Predictive Values of Serotonergic Alterations for Outcome
Study Type
Interventional
2. Study Status
Record Verification Date
December 2002
Overall Recruitment Status
Terminated
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
VA Office of Research and Development
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
Keywords
cocaine dependence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Fenfluramine
Primary Outcome Measure Information:
Title
Side effects
Title
Neuroendocrine changes
Title
Psychological changes
Title
Craving
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laure Buydens-Branchey, M.D.
Organizational Affiliation
VA Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Medical Center
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11209
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Predictive Values of Serotonergic Alterations for Outcome - 2
We'll reach out to this number within 24 hrs